Four-Step Framework for Valve-in-Valve Transcatheter Aortic Valve Replacement for Failed Surgical and Transcatheter Aortic Bioprostheses.

Milos Brankovic, Hassan Akram, Aisha Shabbir, Laith Alhuneafat, Abhishek Sharma

Abstract readReview

In one paragraph

Review in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Preoperative Main Pulmonary Artery Diameter Indexed to Body Surface Area Independently Predicts Mortality After Transcatheter Aortic Valve Implantation in a Chinese Population.Reviews in cardiovascular medicine · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Milos BrankovicCardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.ORCID https://orcid.org/0000-0002-4730-957X

Hassan AkramDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Aisha ShabbirDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Laith AlhuneafatCardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Abhishek SharmaDivision of Cardiology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter aortic valve replacement (TAVR), originally developed to treat native aortic valve disease, has become increasingly adopted in the valve-in-valve (ViV) setting to manage bioprosthetic valve dysfunction of both surgically implanted bioprostheses (TAV-in-SAV) and prior transcatheter valves (TAV-in-TAV). Recent advances have significantly refined the ViV technique to address procedural challenges, including suboptimal hemodynamic outcomes and the risk of coronary obstruction. This review summarizes the current clinical data supporting the use of TAVR in a ViV setting and outlines a structured, four-step framework that encompasses procedural planning, including determining the perioperative risk for a patient, identifying the mode of valve failure, recognizing valve-specific implantation strategies, and assessing concomitant structural lesions. This review also aims to synthesize current evidence into a clinically actionable format, helping to guide heart team discussions, pre-procedural planning, and patient counseling.

Indexed as

bioprosthetic valve failurestructural valve deteriorationtranscatheter aortic valve implantation, TAVItranscatheter aortic valve-in-surigical aortic valvetranscatheter aortic valve-in-transcatheter aortic valvetranscatheter aortic valve replacement, TAVRvalve-in-valve, ViV

Identifiers

PMID41089790

DOI10.31083/RCM43142

PMCPMC12516776

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.